Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.09 CAD | 0.00% | 0.00% | +5.88% |
09/04 | Rakovina Therapeutics Presents At American Association Of Cancer Research Annual Meeting | MT |
2023 | Rakovina Therapeutics Announces Appointment to Scientific Advisory Board | MT |
Sales 2021 | - | Sales 2022 | - | Capitalization | 12.57M 17.18M 1.05B |
---|---|---|---|---|---|
Net income 2021 | -5M -6.83M -417M | Net income 2022 | -2M -2.73M -167M | EV / Sales 2021 | - |
Net cash position 2021 | 2.81 3.84 234.42 | Net cash position 2022 | 0.9 1.23 74.78 | EV / Sales 2022 | - |
P/E ratio 2021 |
-2.14
x | P/E ratio 2022 |
-4.5
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 54.24% |
Current month | -10.00% | ||
1 month | +28.57% | ||
6 months | +12.50% | ||
Current year | +5.88% |
Managers | Title | Age | Since |
---|---|---|---|
Mads Daugaard
PSD | President | - | 01/21/01 |
David Hyman
DFI | Director of Finance/CFO | - | - |
John Langlands
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | 06/19/06 | |
Jeffrey Bacha
CHM | Chairman | 56 | 01/20/01 |
Dennis Brown
BRD | Director/Board Member | 74 | 25/21/25 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.09 | 0.00% | 30,000 |
25/24/25 | 0.09 | 0.00% | 35,000 |
24/24/24 | 0.09 | +5.88% | 20,000 |
23/24/23 | 0.085 | -5.56% | 55,000 |
22/24/22 | 0.09 | 0.00% | 40,000 |
Delayed Quote Toronto S.E., April 26, 2024 at 08:24 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
+5.88% | 4.61M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- RKV Stock